Top pharmaceutical companies located in Canada 2022, by revenue

Total pharmaceutical sales in Canada came to about 34 billion U.S. dollars in 2022. Of this, U.S.-based diversified health company Johnson & Johnson generated over 4.7 billion dollars. Thus, J&J held the largest single market share with over 12 percent. With a significant distance, U.S.-based company Merck was ranked second generating revenues of around 1.8 billion Canadian dollars.Canada in a global context Canada’s pharmaceutical market is among the global top 10 national markets. The market share stands at two percent of the total global pharmaceutical market. In a large part, the Canadian market is dominated by the big pharma companies from the U.S. and Europe. Among the most important Canada-based companies are Apotex and Bausch Health (ex-Valeant Pharmaceuticals). Economic importanceThe drug manufacturing industry is mostly centered in the metropolitan areas of Toronto, Montreal, and Vancouver, and employs over 33 thousand people. As in many other countries, the pharmaceutical sector is one of the most innovative industries in Canada, spending nearöy one billion Canadian dollars on research and development every year. Over 50 percent of pharmaceutical products manufactured in Canada are exported, of which the largest part is to the United States.

2022年，加拿大药品总销售额约为340亿美元。其中，美国多元化健康公司强生（Johnson & Johnson）创造了超过47亿美元的收入。因此，强生公司以超过12%的市场份额占据了最大的单一市场份额。美国公司默克（Merck）以约18亿加元的收入位居第二，与强生公司存在显著差距。在全球范围内，加拿大的药品市场位居全球前十大国家市场之列。该市场在全球药品市场中所占份额为2%。在很大程度上，加拿大市场由来自美国和欧洲的大型制药公司主导。在加拿大本土最重要的公司中包括阿波罗泰克斯（Apotex）和宝洁健康（Bausch Health，前称Valeant Pharmaceuticals）。经济重要性方面，制药行业主要集中在多伦多、蒙特利尔和温哥华等大都市地区，雇佣了超过33,000人。如同许多其他国家一样，制药行业在加拿大是最具创新性的行业之一，每年在研发上投入近10亿加元。加拿大制造的药品中有超过50%出口，其中最大份额出口至美国。